Similar articles

• An overview of the analysis and interpretation of bioavailability studies in man.

  Wagner JG. Wagner JG. Arzneimittelforschung. 1976;26(1A):105-8. Arzneimittelforschung. 1976. PMID: 947190
• Pharmacokinetics of buflomedil after intravenous and oral administration.

  Rey E, Barrier G, d'Athis P, de Lauture D, Richard MO, Lirzin JP, Sureau C, Olive G. Rey E, et al. Int J Clin Pharmacol Ther Toxicol. 1980 Oct;18(10):437-41. Int J Clin Pharmacol Ther Toxicol. 1980. PMID: 7203720
• Absolute intramuscular, oral, and rectal bioavailability of alizapride.

  Houin G, Barre J, Tillement JP. Houin G, et al. J Pharm Sci. 1984 Oct;73(10):1450-3. doi: 10.1002/jps.2600731033. J Pharm Sci. 1984. PMID: 6502497
• [Clinical pharmacokinetics of verapamil and nifedipine].

  Rumiantsev DO, Piotrovskiĭ VK, Metelitsa VI. Rumiantsev DO, et al. Farmakol Toksikol. 1985 Jan-Feb;48(1):99-109. Farmakol Toksikol. 1985. PMID: 3884367 Review. Russian. No abstract available.
• [Are dosage adjustments needed in patients with liver diseases? (author's transl)].

  Münst GJ, Bircher J. Münst GJ, et al. Ther Umsch. 1978 Sep;35(9):756-60. Ther Umsch. 1978. PMID: 360477 Review. German. No abstract available.